title
Approval of a Resolution Authorizing Participation with the State of Texas, Through the Office of the Attorney General, in the Alvogen, Inc., Apotex Corp., Amneal Pharmaceuticals LLC, Kima Pharmaceuticals USA Inc., Indivior Inc., Viatris Inc. (“Mylan”), Sun Pharmaceutical Industries, Inc., and Zydus Pharmaceuticals (USA) Inc. Opioid Settlements, and Approving the Secondary Manufacturers’ Combined Subdivision Participation and Release Form Regarding the Same; Authorizing the City Manager or Her Designee to Execute All Necessary Documents in Connection with the Above on Behalf of the City; and Providing an Effective Date.
request
ADMINISTRATIVE COMMENTS:
The State of Texas, through the Office of the Attorney General, has entered into a settlement agreement with generic opioid manufacturers Alvogen, Inc., Apotex Corp., Amneal Pharmaceuticals LLC, Kima Pharmaceuticals USA Inc., Indivior Inc., Viatris Inc. (“Mylan”), Sun Pharmaceutical Industries, Inc., and Zydus Pharmaceuticals (USA) Inc., and their associated entities (the “Secondary Manufacturers”) regarding their promotion, manufacturing, and distribution of opioids in the state. As a participant in the settlement agreement, the City would receive up to an estimated $14,482.07 over a total of 10 years, as well as funds which will be made available through regional grants in accordance with the Texas Term Sheet adopted by the City Council on November 15, 2021, for uses related to opioid abatement. The Secondary Manufacturers will be subject to injunctive relief, including bans on the promotion of opioids and opioid-related medications, lobbying prohibitions, and certain reporting requirements. To participate in this settlement agreement, the City must authorize the City Manager, or her designee, to execute the Secondary Manufacturers’ Combined Subdivision Participation and Release Form associated with the settlement agreement, releasing certain claims the City might have against the Secondary Manufacturers for past opioid-related actions or failures to act.
RECOMMENDATION:
That the City Council approve the resolution as set forth in the caption above.